In 2025, the private equity industry ushered in a bright moment. The total scale of the industry broke through the 22 trillion mark, a batch of private equity surpassed 10 billion dollars, and the net value of a large number of products reached a record high. Although the A-share market fluctuated and consolidated in November, and the 10 billion private equity performance retreated slightly, many private equity firms still handed over positive returns, and the cumulative earnings since this year have outperformed the index by a large margin. The reporter learned from the channel that many representative products of Yuanlesheng, Xinsizhe, Fosheng, Tongben, and Tongyuan performed more than 50% during the year; quantitative private equity was even more impressive. Behind it was the popularity of SME growth strategies. Many 10 billion quantitative products such as Mingyi, Century Frontier, Meng Xi, and Longqi performed more than 60%.

In 2025, the private equity industry ushered in a bright moment. The total scale of the industry broke through the 22 trillion mark, a batch of private equity surpassed 10 billion dollars, and the net value of a large number of products reached a record high. Although the A-share market fluctuated and consolidated in November, and the 10 billion private equity performance retreated slightly, many private equity firms still handed over positive returns, and the cumulative earnings since this year have outperformed the index by a large margin. The reporter learned from the channel that many representative products of Yuanlesheng, Xinsizhe, Fosheng, Tongben, and Tongyuan performed more than 50% during the year; quantitative private equity was even more impressive. Behind it was the popularity of SME growth strategies. Many 10 billion quantitative products such as Mingyi, Century Frontier, Meng Xi, and Longqi performed more than 60%.